JPH03190865A - Production of optically active 3-phenylglycidic ester compound - Google Patents
Production of optically active 3-phenylglycidic ester compoundInfo
- Publication number
- JPH03190865A JPH03190865A JP33317589A JP33317589A JPH03190865A JP H03190865 A JPH03190865 A JP H03190865A JP 33317589 A JP33317589 A JP 33317589A JP 33317589 A JP33317589 A JP 33317589A JP H03190865 A JPH03190865 A JP H03190865A
- Authority
- JP
- Japan
- Prior art keywords
- optically active
- acid derivative
- formula
- solvent
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Epoxy Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、医薬合成中間体として有用な光学活性トラン
ス−3−フェニルグリジッド酸エステル類化合物の新規
製法に関する。DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to a novel method for producing optically active trans-3-phenylglycidate ester compounds useful as pharmaceutical synthesis intermediates.
(従来技術)
光学活性)・ランス−3−フェニルグリジッド酸エステ
ル類化合物は、冠血管拡張剤として有用な塩酸ジルチア
ゼム及びその他各種医薬化合物の合成原料として重要な
化合物であり、従来、トランス3−(P−メトキシフェ
ニル)グリジッド酸又はそのアルカリ金属塩のラセミ体
を光学活性アミン類で光学分割した後エステル化して製
造する方法(特開昭61−145160.同6O−13
775)が知られている。・(解決しようとする課題)
本発明は、かかる既知方法とは異なる工業的有利な光学
活性3−フェニルグリジッド酸エステル類化合物の新規
製法を提供しようとするものである。(Prior art) Trans-3-phenyl glycidate compounds (optically active) are important compounds as raw materials for the synthesis of diltiazem hydrochloride, which is useful as a coronary vasodilator, and various other pharmaceutical compounds. A method for producing (P-methoxyphenyl) glycidic acid or its alkali metal salt by optically resolving it with an optically active amine and then esterifying it (JP-A-61-145160. JP-A No. 61-145160.
775) is known. - (Problem to be Solved) The present invention aims to provide a new method for producing optically active 3-phenylglyzide acid ester compounds that is different from such known methods and is industrially advantageous.
(課題を解決するための手段)
本発明によれば、一般式
(但し、環へは置換基を有していてもよいフェニル基、
Rは低級アルキル基を表す。)
で示される光学活性トランス−3−フェニルグリジッド
酸エステル類化合物は、一般式
(但し、環へ及びRは前記と同一意味を表し、Xはハロ
ゲン原子を表す。)
で示される2−ハロゲノ−3−オキソ−3−フェニルプ
ロピオン酸誘導体を光学活性アミノ酸誘導体及び低級脂
肪族アルコールの存在下に、金属水素化物で不斉還元し
て、一般式
(但し、環A、R及びXは、前記と同一意味を表す。〕
で示される2−ハロゲノ−3−ヒドロキシ−3=フ工ニ
ルプロピオン酸誘導体とし、次いで、これを分子内閉環
することにより製造することができる。(Means for Solving the Problems) According to the present invention, the general formula (however, a phenyl group which may have a substituent on the ring,
R represents a lower alkyl group. ) The optically active trans-3-phenylglyzide acid ester compound is a 2-halogen compound represented by the general formula (wherein the ring and R represent the same meanings as above, and X represents a halogen atom). -3-oxo-3-phenylpropionic acid derivative is asymmetrically reduced with a metal hydride in the presence of an optically active amino acid derivative and a lower aliphatic alcohol, and the general formula (however, rings A, R and X are It can be produced by preparing a 2-halogeno-3-hydroxy-3=phynylpropionic acid derivative represented by the following and then intramolecularly ring-closing this.
本発明の目的物の例としては、一般式(1)において、
環Aが低級アルキル基、低級アルコキシ基、及びハロゲ
ン原子から選ばれる置換基を有していてもよいフェニル
基、Rが直鎖又は分岐鎖低級アルキル基などである化合
物が挙げられ、より具体的には、環Aがフェニル基、4
−メチルフェニル基、4−メトキシフェニル基又は4−
クロロフェニル基、Rがメチル基、エチル基、イソプロ
ピル基、t−ブチル基等である化合物が挙げられる。As an example of the object of the present invention, in general formula (1),
Examples include compounds in which ring A is a phenyl group which may have a substituent selected from a lower alkyl group, a lower alkoxy group, and a halogen atom, and compounds in which R is a linear or branched lower alkyl group, and more specific , ring A is a phenyl group, 4
-methylphenyl group, 4-methoxyphenyl group or 4-
Examples thereof include a chlorophenyl group, and compounds in which R is a methyl group, an ethyl group, an isopropyl group, a t-butyl group, and the like.
本発明の第一工程の不斉還元反応は、2−ハロゲノ−3
−オキソ−3−フェニルプロピオン酸誘導体[11)に
、適当な溶媒中、光学活性アミノ酸誘導体と低級脂肪族
アルコールの存在下に金属水素化物を作用させることに
より実施できる。The asymmetric reduction reaction of the first step of the present invention is 2-halogeno-3
This can be carried out by reacting the -oxo-3-phenylpropionic acid derivative [11] with a metal hydride in the presence of an optically active amino acid derivative and a lower aliphatic alcohol in an appropriate solvent.
光学活性アミノ酸誘導体としては、アミノ基が保護され
たセリン、システィン、シスチン、またはそれらのカル
ボキシル基がアルコールに還元された誘導体が好適に使
用できる。アミノ基の保護基としては、通常用いられる
もので良く、例えば、ベンゾイル基、アセチル基、トシ
ル基、ベンジルオキシカルボニル基、L−ブトキシカル
ボニル基、L−アミルオキシカルボニル基、2−ナラ1
−イル基、p−ニトロカルボベンゾキシ基等が挙げられ
、とりわけ、ベンゾイル基が好ましい。これらの光学活
性アミノ酸誘導体は原料化合物(II)に対して1〜5
倍モル、とりわけ、2〜3倍モル用いるのが好ましい。As the optically active amino acid derivative, serine, cysteine, cystine with a protected amino group, or derivatives thereof in which the carboxyl group is reduced to alcohol can be suitably used. As the protecting group for the amino group, commonly used ones may be used, such as benzoyl group, acetyl group, tosyl group, benzyloxycarbonyl group, L-butoxycarbonyl group, L-amyloxycarbonyl group, 2-nara1
-yl group, p-nitrocarbobenzoxy group, etc., and benzoyl group is particularly preferred. These optically active amino acid derivatives have a molecular weight of 1 to 5 with respect to starting compound (II).
It is preferable to use twice the mole, especially 2 to 3 times the mole.
低級脂肪族アルコールとしては、メタノール、エタノー
ル、イソプロパツール、L−ブタノール等の炭素数1〜
6の直鎖又は分岐鎖状のものがあげられ、とりわけ、イ
ソプロパツール、し−ブタノール等の分岐基を有する低
級脂肪族アルコールが好適に使用できる。該アルコール
の使用量は原料化合物(II)に対し1〜5倍モル、と
りわけ、1〜2倍モルが好ましい。Examples of lower aliphatic alcohols include those having 1 or more carbon atoms, such as methanol, ethanol, isopropanol, and L-butanol.
Among them, lower aliphatic alcohols having a branched group such as isopropanol and butanol can be preferably used. The amount of alcohol to be used is preferably 1 to 5 times the mole, particularly 1 to 2 times the mole of the starting compound (II).
金属水素化物としては、水素化ホウ素リチウム、水素化
ホウ素ナトリウム、水素化アルミニウムリチウム等があ
げられ、とりわけ、水素化ホウ素リチウムが好適である
。その使用量は、原料化合物(II)に対し1〜5倍モ
ル、とりわけ、3〜4倍モルが好ましい。Examples of the metal hydride include lithium borohydride, sodium borohydride, lithium aluminum hydride, and lithium borohydride is particularly preferred. The amount used is preferably 1 to 5 times the mole, particularly 3 to 4 times the mole of the starting compound (II).
溶媒としては、例えば、ヘキサン等の炭化水素系溶媒、
ベンゼン、トルエン、キシレン等の芳香族系溶媒、エチ
ルエーテル、テトラヒドロフラン、ジオキサン、ジグリ
ム等のエーテル系溶媒など反応に関与しない不活性溶媒
であればよく、これらは単独もしくは適宜混合して用い
ることができる。Examples of the solvent include hydrocarbon solvents such as hexane,
Any inert solvent that does not participate in the reaction may be used, such as aromatic solvents such as benzene, toluene, and xylene, and ether solvents such as ethyl ether, tetrahydrofuran, dioxane, and diglyme, and these may be used alone or in appropriate mixtures. .
本不斉還元反応は、先ず、窒素、アルゴン等の不活性ガ
ス雰囲気下で、光学活性アミノ酸誘導体と低級脂肪族ア
ルコールとを溶媒中で溶解し、金属水素化物を加えて、
必要に応じて加熱しく第1反応)、次いで、冷却下に2
−ハロゲノ−3−オキソ−3−フェニルプロピオン酸誘
導体を加えること(第2反応)により好適に実施できる
。第1反応は、室温ないし還流温度で実施するのが好ま
しく、第2反応は、−150〜0°C1とりわけ、10
0〜−30°Cで実施するのが好ましい。In this asymmetric reduction reaction, first, an optically active amino acid derivative and a lower aliphatic alcohol are dissolved in a solvent under an inert gas atmosphere such as nitrogen or argon, and a metal hydride is added.
(1st reaction) with heating if necessary, then 2nd reaction with cooling.
This reaction can be suitably carried out by adding a -halogeno-3-oxo-3-phenylpropionic acid derivative (second reaction). The first reaction is preferably carried out at room temperature to reflux temperature, the second reaction is carried out at -150 to 0 °C, especially at 10
Preferably, the temperature is 0 to -30°C.
続く第2工程の2−ハロゲノ−3−ヒドロキシ3−フェ
ニルプロピオン酸誘導体(III)の分子内閉環反応は
、溶媒中、塩基の存在下で好適に実施することができる
。溶媒としては、メタノール、エタノール等の低級アル
カノールを好適に使用することができる。また、塩基と
しては、ナトリウムメトキシド、ナトリウムエトキシド
、リチウムメトキシド等のアルカリ金属アルコキシドが
好適に使用でき、その使用量は2−ハロゲノ−3−ヒド
ロキシ−3−フェニルプロピオン酸誘In(III)の
約0.8〜1.2倍モルが好ましい。本反応は、10°
C〜50°C1とりわけ、0°C〜室温で好適に進行す
る。The subsequent intramolecular ring-closing reaction of the 2-halogeno-3-hydroxy 3-phenylpropionic acid derivative (III) in the second step can be suitably carried out in a solvent in the presence of a base. As the solvent, lower alkanols such as methanol and ethanol can be suitably used. In addition, as the base, alkali metal alkoxides such as sodium methoxide, sodium ethoxide, and lithium methoxide can be suitably used, and the amount used is 2-halogeno-3-hydroxy-3-phenylpropionic acid derivative In(III). It is preferably about 0.8 to 1.2 times the molar amount. This reaction is carried out at 10°
C to 50° C1, particularly preferably at 0° C to room temperature.
尚、本発明方法の原料化合物である2−ハロゲノ−3−
オキソ−3−フェニルプロピオン酸誘導体(II)は、
一般式
(但し、環Aは前記と同一意味を表す。)で示されるア
セトフェノン頻化合物を塩基の存在下、ジ低級アルキル
カーボネートと反応させて、一般式
(但し、環A及びRは前記と同一意味を表す。)で示さ
れる3−オキソ−3−フェニルプロピオン酸誘導体を製
し、ついでこれをハロゲン化することにより製造するこ
とが出来る。In addition, 2-halogeno-3- which is a raw material compound for the method of the present invention
Oxo-3-phenylpropionic acid derivative (II) is
An acetophenone compound represented by the general formula (however, ring A has the same meaning as above) is reacted with di-lower alkyl carbonate in the presence of a base, and It can be produced by preparing a 3-oxo-3-phenylpropionic acid derivative represented by the following formula and then halogenating it.
(実施例)
(1) N、 N’ −ジベンゾイル=L−シスチ
ン1.614g、t−ブタノール357■及びテトラヒ
ドロフラン20 mlの懸濁液に、アルゴン雰囲気下に
水素化ホウ素リチウム237■のテトラヒドロフラン1
6m1溶液を加えて1時間還流した。ついで、2−クロ
ロ−3−オキソ−3−(4−メトキシフェニル)プロピ
オン酸メチルエステル728■のテトラヒドロフラン1
0艷溶液を−65〜−70°Cで加え、同温で1時間攪
拌した。反応後、反応液に10%塩酸を加えて分解した
のち、5%炭酸水素ナトリウム水溶液を加えてp Hを
9〜10に調整し、エチルエーテルで抽出した。抽出液
を水洗、乾燥した後、溶媒を留去して得られる残渣の黄
色油状物740■をシリカゲルカラムクロマトグラフィ
ー(溶媒;ヘキサン:酢酸エチル=3 : 1)で精製
することにより、2−クロロ−3−ヒドロキシ−3(4
−メトキシフェニル)プロピオン酸メチルエステルのス
レオ(2R,3S)体及びエリスロ(2S、33)体の
混合物660mgを無色結晶として得た。(Example) (1) To a suspension of 1.614 g of N, N'-dibenzoyl=L-cystine, 357 μg of t-butanol, and 20 ml of tetrahydrofuran, 237 μg of lithium borohydride was added to 1 ml of tetrahydrofuran under an argon atmosphere.
6ml of the solution was added and the mixture was refluxed for 1 hour. Then, 728 μl of 2-chloro-3-oxo-3-(4-methoxyphenyl)propionic acid methyl ester in tetrahydrofuran 1
The solution was added at -65 to -70°C and stirred at the same temperature for 1 hour. After the reaction, 10% hydrochloric acid was added to the reaction solution for decomposition, and then 5% aqueous sodium hydrogen carbonate solution was added to adjust the pH to 9-10, followed by extraction with ethyl ether. After washing the extract with water and drying, the solvent was distilled off and the resulting yellow oily residue was purified by silica gel column chromatography (solvent: hexane: ethyl acetate = 3: 1) to obtain 2-chloro -3-hydroxy-3(4
660 mg of a mixture of threo (2R, 3S) and erythro (2S, 33) forms of -methoxyphenyl)propionate methyl ester was obtained as colorless crystals.
I R(liquid ) : 34B0.1750
.1610.1515゜1250、1175.1030
.830cm−’NMRδ(CDCh ):
(スレオ体) 2.89(III、d、3.9 Hz
)3.67(311,s )、 3.80(311,
s )+ 4.42(III、d。IR (liquid): 34B0.1750
.. 1610.1515°1250, 1175.1030
.. 830 cm-'NMRδ (CDCh): (threo body) 2.89 (III, d, 3.9 Hz
) 3.67 (311, s ), 3.80 (311,
s ) + 4.42 (III, d.
6.8 Hz)、 5.08(ill、dd、 3.9
and 6.8 Hz )。6.8 Hz), 5.08(ill, dd, 3.9
and 6.8 Hz).
6.89(21Ld、8.81(z )、 7.30(
2tl、d、8.8](z )(エリスロ体) 2.8
9(ill、d、4.611z )、3.80(611
,s )、4.35(III、d、8.1 ](z )
、 5.00(ill。6.89(21Ld, 8.81(z), 7.30(
2tl, d, 8.8] (z) (erythro body) 2.8
9 (ill, d, 4.611z), 3.80 (611
, s ), 4.35 (III, d, 8.1 ] (z )
, 5.00 (ill.
dd、4.6 and 8.11(z )、 6.91
(211,d、8.811z )+7.32(2H,d
、8.8)fz )(2)上記(1)で得た結晶をメタ
ノール16m2に溶解0
した溶液にナトリウムメトキシド153■のメタノール
5rnl溶液を0℃で加え、同温で90分間攪拌した後
、室温で10分間攪拌した。ついで、反応液に水を加え
てエチルエーテルで抽出した。抽出液を飽和食塩水で洗
浄、乾燥した後、溶媒を留去した。得られた残渣の油状
物をシリカゲルカラムクロマトグラフィー(溶媒;ヘキ
サン:酢酸エチル=3 : 1)にて精製することによ
り(2R,3S)−3−(4−メトキシフェニル)グリ
ジッド酸メチルエステル506mgを得た。dd, 4.6 and 8.11(z), 6.91
(211,d,8.811z)+7.32(2H,d
, 8.8) fz ) (2) To a solution of the crystals obtained in (1) above dissolved in 16 m2 of methanol, a solution of 153 μm of sodium methoxide in 5 rnl of methanol was added at 0°C, and after stirring at the same temperature for 90 minutes. and stirred at room temperature for 10 minutes. Then, water was added to the reaction solution, and the mixture was extracted with ethyl ether. After washing the extract with saturated brine and drying, the solvent was distilled off. The resulting oily residue was purified by silica gel column chromatography (solvent: hexane:ethyl acetate = 3:1) to obtain 506 mg of (2R,3S)-3-(4-methoxyphenyl)glycid acid methyl ester. Obtained.
〔α) =、−143,3’ (C=0.30 、メ
タノール)(光学純度:82%、HPLCより)
I R(Nujol ) : 2920.1730.
1615.15201440、1250 1030.8
40cmNMRδ(CDCl5): 3.50 (II
I、d、1.811y、 )3.80(3H,s )+
3.81(3H,s )、 4.04(LH,d。[α) =, -143,3' (C=0.30, methanol) (optical purity: 82%, from HPLC) IR (Nujol): 2920.1730.
1615.15201440, 1250 1030.8
40cmNMRδ (CDCl5): 3.50 (II
I, d, 1.811y, )3.80(3H,s )+
3.81 (3H, s), 4.04 (LH, d.
1.811z )+ 6.87(28,d、 9.01
1z )、 7.20(2H。1.811z)+6.87(28,d, 9.01
1z), 7.20 (2H.
d、9.011z )
Mass (E T ) : 208 (M)参考
例
(1−a) ナトリウム30.7 gをトルエン30
0m2に加え、93゛Cに加熱した後、はげしく攪拌し
ながら放冷し、ナトリウムをサンド状にした。これにジ
メチルカーボネート300gのトルエン600m1溶液
を加え、さらに、84〜86℃で、p−メトキシアセト
フェノン100gのトルエン250mEI液を2時間1
5分を要して滴下した。滴下後、82〜83℃で1.5
時間加熱攪拌した後、溶媒を留去し、残渣にイソプロピ
ルエーテル11を加え、結晶をろ取し、イソプロピルエ
ーテル500mA!で洗浄した。この結晶を酢酸100
gを含む氷−酢酸エチルの混合物中に加え、酢酸エチル
にて抽出した。d, 9.011z) Mass (ET): 208 (M) Reference example (1-a) 30.7 g of sodium was added to 30 g of toluene
After heating to 93°C, the mixture was allowed to cool while stirring vigorously, and the sodium was formed into a sandwich. A solution of 300 g of dimethyl carbonate in 600 ml of toluene was added to this, and then a solution of 250 mEI of toluene containing 100 g of p-methoxyacetophenone was added at 84 to 86°C for 2 hours.
The dropwise addition took 5 minutes. 1.5 at 82-83℃ after dropping
After heating and stirring for an hour, the solvent was distilled off, isopropyl ether 11 was added to the residue, and the crystals were collected by filtration. Washed with. Add this crystal to 100% acetic acid.
The mixture was added to an ice-ethyl acetate mixture containing g and extracted with ethyl acetate.
抽出液を、5%炭酸水素ナトリウムで洗浄し、水洗、乾
燥後、溶媒を留去することにより、3−オキソ−3−(
4−メトキシフェニル)プロピオン酸メチルエステル1
31.6 gを油状物として得た。The extract was washed with 5% sodium hydrogen carbonate, washed with water, dried, and the solvent was distilled off to give 3-oxo-3-(
4-Methoxyphenyl)propionic acid methyl ester 1
31.6 g were obtained as an oil.
収率: 94.9%
T R(liquid ) : 3625〜3450.
1740.1665 cm−’NMRδ(CDCl3
):3.74(311,S )+ 3.87(311,
S )1
2
3.95(2H,s )、 6.94(2+1.d、
9.2H7)+ 7.92(211,d、 9
.211z )(1−b) 水素化ナトリウム(6
0χ油懸濁液)2.7gをテトラヒドロフラン25m1
に懸濁させ、これに p−メトキシアセトフェノン5.
0gを加え、55℃にて、ジメチルカーボネート6.0
gを10分間で加えた。ついで6時間還流した後、以下
(1−a)と同様に実施することにより3−オキソ−3
−(4−メトキシフェニル)プロピオン酸メチルエステ
ル6.3gを油状物として得た。Yield: 94.9% T R (liquid): 3625-3450.
1740.1665 cm-'NMRδ(CDCl3
): 3.74 (311, S ) + 3.87 (311,
S ) 1 2 3.95 (2H, s ), 6.94 (2+1.d,
9.2H7)+7.92(211,d, 9
.. 211z ) (1-b) Sodium hydride (6
0x oil suspension) 2.7g in tetrahydrofuran 25ml
5. Suspend in p-methoxyacetophenone.
Add 0g of dimethyl carbonate at 55°C.
g was added over 10 minutes. After refluxing for 6 hours, 3-oxo-3 was prepared in the same manner as in (1-a) below.
6.3 g of -(4-methoxyphenyl)propionic acid methyl ester were obtained as an oil.
収率: 91.3%
(2)上記(1)で得た3−オキソ−3−(4メトキシ
フエニル)プロピオン酸メチルエステル131gを四塩
化炭素1.37!に熔解し、スルフリルクロリド85
gを45〜50℃で1時間を要して滴下した。滴下後、
同温で1時間攪拌した後、冷却し、水洗、乾燥した後、
溶媒を留去して得られる残渣の油状物を減圧下で蒸溜す
ることにより、2−り コロ−3−オキソ−3−(4−
メトキシフェニル)プロピオン酸メチルエステル140
gを得た。Yield: 91.3% (2) 131 g of 3-oxo-3-(4methoxyphenyl)propionic acid methyl ester obtained in (1) above was converted to 1.37 g of carbon tetrachloride! Sulfuryl chloride 85
g was added dropwise at 45 to 50°C over 1 hour. After dripping,
After stirring at the same temperature for 1 hour, cooling, washing with water, and drying,
By distilling the oily residue obtained by distilling off the solvent under reduced pressure, 2-coro-3-oxo-3-(4-
methoxyphenyl)propionic acid methyl ester 140
I got g.
収率:92.1%
b、p、 143.5〜145℃10.3 mmmm1
l R(liquid ) ; 1750.1660
c+n−’NMRδ(CDCl3 ):3.82(3
+1.S )、 3.88(3tl、s )。Yield: 92.1% b, p, 143.5-145°C 10.3 mmmm1
l R (liquid); 1750.1660
c+n-'NMRδ(CDCl3): 3.82(3
+1. S), 3.88 (3tl,s).
5.9D IILs )、 6.96(2H,d、 9
.0tlz )+ 7.97(2tl、d、 9.01
1z )
(発明の効果)
本発明方法によれば、2−ハロゲノ−3−オキソ−3−
フェニルプロピオン酸誘導体のケトン部分を選択的に不
斉還元した後、分子内閉環を行うという簡単な反応操作
で光学活性トランス−3フ工ニルグリジツド酸エステル
類化合物を効率よく製造することができる。5.9D IILs), 6.96(2H,d, 9
.. 0tlz ) + 7.97 (2tl, d, 9.01
1z) (Effect of the invention) According to the method of the present invention, 2-halogeno-3-oxo-3-
Optically active trans-3-phenyl glycidate compounds can be efficiently produced by a simple reaction operation of selectively asymmetrically reducing the ketone moiety of a phenylpropionic acid derivative and then performing intramolecular ring closure.
3 43 4
Claims (1)
Rは低級アルキル基、Xはハロゲン原子を表す。) で示される2−ハロゲノ−3−オキソ−3−フェニルプ
ロピオン酸誘導体を光学活性アミノ酸誘導体及び低級脂
肪族アルコールの存在下に、金属水素化物で不斉還元し
て、一般式▲数式、化学式、表等があります▼〔III〕 (但し、環A、R及びXは、前記と同一意味を表す。) で示される2−ハロゲノ−3−ヒドロキシ−3−フェニ
ルプロピオン酸誘導体を製し、次いで、生成物を分子内
閉環することを特徴とする一般式▲数式、化学式、表等
があります▼〔 I 〕 (但し、環A及びRは前記と同一意味を表す。)で示さ
れる光学活性トランス−3−フェニルグリシッド酸エス
テル類化合物の製法。(1) General formula ▲ Numerical formula, chemical formula, table, etc. ▼ [II] (However, ring A is a phenyl group that may have a substituent,
R represents a lower alkyl group, and X represents a halogen atom. ) is asymmetrically reduced with a metal hydride in the presence of an optically active amino acid derivative and a lower aliphatic alcohol to obtain the general formula ▲ mathematical formula, chemical formula, There are tables, etc. ▼ [III] (However, rings A, R and X have the same meanings as above.) A 2-halogeno-3-hydroxy-3-phenylpropionic acid derivative is prepared, and then, The optically active trans- Method for producing 3-phenylglycidic acid ester compounds.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1333175A JPH0660169B2 (en) | 1989-12-21 | 1989-12-21 | Process for producing optically active 3-phenylglycidate compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1333175A JPH0660169B2 (en) | 1989-12-21 | 1989-12-21 | Process for producing optically active 3-phenylglycidate compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH03190865A true JPH03190865A (en) | 1991-08-20 |
| JPH0660169B2 JPH0660169B2 (en) | 1994-08-10 |
Family
ID=18263140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1333175A Expired - Lifetime JPH0660169B2 (en) | 1989-12-21 | 1989-12-21 | Process for producing optically active 3-phenylglycidate compounds |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0660169B2 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0356471A (en) * | 1989-07-18 | 1991-03-12 | Sanofi Sa | Preparation of glycidic ester and intermediate thereof, i.e., diastereoisomer and benzothiazepine-one derivative thereof |
-
1989
- 1989-12-21 JP JP1333175A patent/JPH0660169B2/en not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0356471A (en) * | 1989-07-18 | 1991-03-12 | Sanofi Sa | Preparation of glycidic ester and intermediate thereof, i.e., diastereoisomer and benzothiazepine-one derivative thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0660169B2 (en) | 1994-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20040030660A (en) | Method of mycophenolate mofetil preparation | |
| IE65735B1 (en) | Process for the production of O2,2'-anhydro-1-(beta-D-arabinofuranosyl)thymine | |
| JPH03190865A (en) | Production of optically active 3-phenylglycidic ester compound | |
| 岡田至 et al. | Synthesis and acaricidal activity of bicyclic pyrazole-3-carboxamide derivatives | |
| JPS61145159A (en) | Novel optically active propionic acid ester derivative and preparation thereof | |
| JPS61268663A (en) | Production of optically active 2-hydroxy-3,3-disubstituted propionic acid | |
| JPH01226881A (en) | Production of compound of optically active 3-phenylglycidic acid esters | |
| JPH03167167A (en) | Production of 3,4-epoxybutyric acid ester and its intermediate | |
| JP3740783B2 (en) | Process for producing 4- (2-alkenyl) -2,5-oxazolidinediones | |
| EP0599732B1 (en) | Derivatives of 1-phenylbicyclo-2,2,2-octane, their preparation process and pharmaceutical compositions containing them | |
| JPH0222254A (en) | 2,3-diaminopropionic acid derivative | |
| KR100445781B1 (en) | Process for preparing (S)-1-acetyl-2-pyrrolidinecarboxamide | |
| KR960007530B1 (en) | Method for preparing sulfonylurea derivative | |
| JPH0641066A (en) | Production of pyrrole derivative | |
| JPS63211264A (en) | Production of indolines | |
| JPH0597735A (en) | Production of optically active secondary alcohol | |
| JP3538889B2 (en) | Method for producing alkylthioacetamide | |
| JP2733256B2 (en) | 4-mercaptopyrazolidine derivative | |
| JP3669724B2 (en) | Process for producing optically active 3- (p-alkoxyphenyl) glycidic acid ester derivative | |
| JPH03190843A (en) | 2-halogeno-3-oxo-3-phenylpropionic acid derivative and production thereof | |
| JPS5935369B2 (en) | Stereoselective synthesis method for optically active compounds | |
| JPH07258234A (en) | Production of 1,3,4-oxadiazole-2(3h)-thione compound | |
| JPS61204189A (en) | Production of novel compound having penam ring | |
| JPS61200977A (en) | Novel thiazolidine derivative | |
| JPS6122030A (en) | Reductive pinacol rearrangement reaction |